Implantable-Device Firmware Audit Record

PROBLEM: On January 9, 2017, the FDA confirmed cybersecurity vulnerabilities in St. Jude Medical implantable cardiac devices — pacemakers and defibrillators — with the Merlin@home Transmitter: if exploited, an unauthorized user could remotely access the device, rapidly deplete its battery, and administer inappropriate pacing or shocks. About 465,000 devices in the United States were affected. A firmware patch was approved and rolled out. No patients were harmed, and no attacks using the flaws were reported or discovered. The case is the documented precedent that an implanted, network-connected device can carry a remotely exploitable flaw — and that the lawful response is a verified firmware patch delivered through the manufacturer, not a claim about who planted it. But firmware audit records for implanted devices live in the manufacturer's files, not in a shared defensive record.

SOLUTION: An implantable-device firmware audit record: every implanted, network-connected device logged with its firmware version, its known vulnerabilities, its patch status, and its remote-access path — so a flaw in a device inside a person's body is tracked like any other critical vulnerability, with the patch verified.

EVIDENCE BASIS: DOCUMENTED — FDA Safety Communication, Jan 9, 2017 (confirmed vulnerabilities; Merlin@home Transmitter; battery depletion and inappropriate pacing/shocks); ~465,000 U.S. devices; firmware patch approved and rolled out; no harm reported, no attacks discovered. Sources: FDA; DHS ICS-CERT advisory; AP, Jan 11, 2017.